one of the best companies in #medicinalcannabis space imo, Low MC, great management, kicking goals, runs on strong fundamentals, backed by IP real world data. 7 clinics,, Potential of OTC S3 registration with TGA followed by FDA registration etc.... CAN Partnership allows CAN's IP gelpell technology (allows better absorption into bloodstream) combined with formulation of EMD into an Oral Capsule ....(an end product we could potentially see on Pharmacy shelfs in coming years) Original Entry 8.8c, consistently topping up on trace backs...... My biggest holding so far.... Long term hold, expecting it to reach $1 in 2021..... This company runs on strong fundamentals so this is not a pump & dump stock.....
EMD Price at posting:
22.0¢ Sentiment: Buy Disclosure: Held
